AI-generated summary
This review describes the mechanisms of low-level laser therapy (photobiomodulation) at the cellular and tissue level and discusses animal studies and human clinical trials in neurology, including stroke, traumatic brain injury, degenerative brain disease, spinal cord injury, and peripheral nerve regeneration. The abstract does not report pooled findings or a single overall conclusion about effectiveness.
- Who or what was studied
- Animal studies and human clinical trials of low-level laser therapy for neurological indications
- Limits stated in the abstract
- The abstract is a narrative review overview and does not state a count of included studies, participants, or quantitative results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Stroke, Reactive oxygen species, Adenosine triphosphate, Traumatic brain injury, Photobiomodulation, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.